The notion that T cells are primed and ready to fight tumors, but are limited by the tumor microenvironment has been demonstrated in patients with melanoma in which lymphocytes from excised tumor masses will expand when supplemented with IL-2 [31]. Here, IL2 is linked to neoplasm.